|
Search
Collections
Benchmarks
Upload document
Product
IRDye800CW-nimotuzumab
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
lung cancer
Clinical trial
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
Status: Recruiting
, Estimated PCD: 2026-09-01
